A Manual To Reduce The Risk Of Hiv And Other Blood Borne Infections In Drug Users
Download A Manual To Reduce The Risk Of Hiv And Other Blood Borne Infections In Drug Users full books in PDF, epub, and Kindle. Read online free A Manual To Reduce The Risk Of Hiv And Other Blood Borne Infections In Drug Users ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Author | : National Research Council and Institute of Medicine |
Publisher | : National Academies Press |
Total Pages | : 352 |
Release | : 1995-09-14 |
Genre | : Medical |
ISBN | : 0309176212 |
This volume addresses the interface of two major national problems: the epidemic of HIV-AIDS and the widespread use of illegal injection drugs. Should communities have the option of giving drug users sterile needles or bleach for cleaning needs in order to reduce the spread of HIV? Does needle distribution worsen the drug problem, as opponents of such programs argue? Do they reduce the spread of other serious diseases, such as hepatitis? Do they result in more used needles being carelessly discarded in the community? The panel takes a critical look at the available data on needle exchange and bleach distribution programs, reaches conclusions about their efficacy, and offers concrete recommendations for public policy to reduce the spread of HIV/AIDS. The book includes current knowledge about the epidemiologies of HIV/AIDS and injection drug use; characteristics of needle exchange and bleach distribution programs and views on those programs from diverse community groups; and a discussion of laws designed to control possession of needles, their impact on needle sharing among injection drug users, and their implications for needle exchange programs.
Author | : Julia S. Garner |
Publisher | : |
Total Pages | : 92 |
Release | : 1983 |
Genre | : Cross infection |
ISBN | : |
Author | : |
Publisher | : |
Total Pages | : 118 |
Release | : 2000 |
Genre | : AIDS (Disease) |
ISBN | : |
Author | : National Academies of Sciences, Engineering, and Medicine |
Publisher | : National Academies Press |
Total Pages | : 483 |
Release | : 2017-09-28 |
Genre | : Medical |
ISBN | : 0309459575 |
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Author | : National Institute on Drug Abuse |
Publisher | : |
Total Pages | : 114 |
Release | : 2000 |
Genre | : AIDS (Disease) |
ISBN | : |
Author | : |
Publisher | : |
Total Pages | : 40 |
Release | : 2002 |
Genre | : Drug addicts |
ISBN | : |
Author | : United States. Congress. House. Committee on Government Reform |
Publisher | : |
Total Pages | : 204 |
Release | : 2004 |
Genre | : Medical |
ISBN | : |
Author | : Bill Sanders |
Publisher | : Springer Science & Business Media |
Total Pages | : 323 |
Release | : 2012-09-14 |
Genre | : Social Science |
ISBN | : 9048189217 |
Carefully selected to reflect the latest research at the interface between public health and criminal justice in the US, these contributions each focus on an aspect of the relationship. How, for example, might a person’s criminal activity adversely affect their health or their risk of exposure to HIV infection? The issues addressed in this volume are at the heart of policy in both public health and criminal justice. The authors track a four-fold connection between the two fields, exploring the mental and physical health of incarcerated populations; the health consequences of crime, substance abuse, violence and risky sexual behaviors; the extent to which high crime rates are linked to poor health outcomes in the same neighborhood; and the results of public health interventions among traditional criminal justice populations. As well as exploring these urgent issues, this anthology features a wealth of remarkable interdisciplinary contributions that see public health researchers focusing on crime, while criminologists attend to public health issues. The papers provide empirical data tracking, for example, the repercussions on public health of a fear of crime among residents of high-crime neighborhoods, and the correlations between HIV status and outcomes, and an individual’s history of criminal activity. Providing social scientists and policy makers with vital pointers on how the criminal justice and public health sectors might work together on the problems common to both, this collection breaks new ground by combining the varying perspectives of a number of key disciplines.
Author | : National Clearinghouse for Alcohol and Drug Information (U.S.). |
Publisher | : |
Total Pages | : 116 |
Release | : 2001 |
Genre | : Government publications |
ISBN | : |
Author | : National Academies of Sciences, Engineering, and Medicine |
Publisher | : National Academies Press |
Total Pages | : 187 |
Release | : 2016-06-01 |
Genre | : Medical |
ISBN | : 0309438020 |
Hepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of world's hepatocellular carcinoma and more than half of all fatal cirrhosis. In 2013 viral hepatitis, of which hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most common types, surpassed HIV and AIDS to become the seventh leading cause of death worldwide. The world now has the tools to prevent hepatitis B and cure hepatitis C. Perfect vaccination could eradicate HBV, but it would take two generations at least. In the meantime, there is no cure for the millions of people already infected. Conversely, there is no vaccine for HCV, but new direct-acting antivirals can cure 95 percent of chronic infections, though these drugs are unlikely to reach all chronically-infected people anytime soon. This report, the first of two, examines the feasibility of hepatitis B and C elimination in the United States and identifies critical success factors. The phase two report will outline a strategy for meeting the elimination goals discussed in this report.